PNC Financial Services Group’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.6K Buy
+4,828
New +$85.3K ﹤0.01% 2945
2026
Q1
Sell
-42
Closed -$705 5234
2025
Q4
$705 Sell
42
-7,298
-99% -$123K ﹤0.01% 4768
2025
Q3
$114K Hold
7,340
﹤0.01% 2717
2025
Q2
$94K Sell
7,340
-6,360
-46% -$78.4K ﹤0.01% 2747
2025
Q1
$174K Hold
13,700
﹤0.01% 2283
2024
Q4
$180K Hold
13,700
﹤0.01% 2293
2024
Q3
$207K Sell
13,700
-1,702
-11% -$25.8K ﹤0.01% 2151
2024
Q2
$218K Buy
15,402
+2,087
+16% +$28.2K ﹤0.01% 2080
2024
Q1
$181K Buy
+13,315
New +$184K ﹤0.01% 2252
2023
Q3
Sell
-17
Closed -$230 4665
2023
Q2
$230 Hold
17
﹤0.01% 4657
2023
Q1
$237 Hold
17
﹤0.01% 4586
2022
Q4
$242 Hold
17
﹤0.01% 4620
2022
Q3
$0 Sell
17
-1,668
-99% -$24.9K ﹤0.01% 4519
2022
Q2
$24K Sell
1,685
-463
-22% -$6.99K ﹤0.01% 3406
2022
Q1
$36K Buy
2,148
+500
+30% +$8.61K ﹤0.01% 3288
2021
Q4
$32K Buy
1,648
+15
+0.9% +$302 ﹤0.01% 3340
2021
Q3
$34K Sell
1,633
-6,806
-81% -$146K ﹤0.01% 3276
2021
Q2
$181K Buy
8,439
+6,847
+430% +$138K ﹤0.01% 2284
2021
Q1
$31K Buy
1,592
+13
+0.8% +$268 ﹤0.01% 3220
2020
Q4
$31K Buy
1,579
+15
+1% +$277 ﹤0.01% 3153
2020
Q3
$27K Buy
1,564
+12
+0.8% +$215 ﹤0.01% 3075
2020
Q2
$28K Hold
1,552
﹤0.01% 3053
2020
Q1
$23K Buy
1,552
+19
+1% +$311 ﹤0.01% 3038
2019
Q4
$27K Buy
1,533
+11
+0.7% +$181 ﹤0.01% 3194
2019
Q3
$23K Buy
1,522
+14
+0.9% +$224 ﹤0.01% 3283
2019
Q2
$25K Buy
1,508
+13
+0.9% +$214 ﹤0.01% 3256
2019
Q1
$26K Sell
1,495
-253
-14% -$4.37K ﹤0.01% 3246
2018
Q4
$26K Buy
1,748
+595
+52% +$10.5K ﹤0.01% 3193
2018
Q3
$24K Hold
1,153
﹤0.01% 3363
2018
Q2
$21K Sell
1,153
-6
-0.5% -$113 ﹤0.01% 3424
2018
Q1
$21K Hold
1,159
﹤0.01% 3410
2017
Q4
$22K Sell
1,159
-200
-15% -$4K ﹤0.01% 3360
2017
Q3
$29K Hold
1,359
﹤0.01% 3189
2017
Q2
$29K Hold
1,359
﹤0.01% 3170
2017
Q1
$26K Hold
1,359
﹤0.01% 3176
2016
Q4
$23K Sell
1,359
-400
-23% -$7.02K ﹤0.01% 3173
2016
Q3
$32K Sell
1,759
-150
-8% -$2.83K ﹤0.01% 3019
2016
Q2
$33K Sell
1,909
-1,193
-38% -$22K ﹤0.01% 3029
2016
Q1
$56K Sell
3,102
-1,431
-32% -$26K ﹤0.01% 2768
2015
Q4
$106K Sell
4,533
-319
-7% -$7.91K ﹤0.01% 2417
2015
Q3
$109K Hold
4,852
﹤0.01% 2470
2015
Q2
$136K Sell
4,852
-1,300
-21% -$36K ﹤0.01% 2461
2015
Q1
$169K Sell
6,152
-1,505
-20% -$41K ﹤0.01% 2350
2014
Q4
$191K Sell
7,657
-872
-10% -$20.9K ﹤0.01% 2102
2014
Q3
$188K Hold
8,529
﹤0.01% 2023
2014
Q2
$177K Hold
8,529
﹤0.01% 1984
2014
Q1
$186K Buy
8,529
+17
+0.2% +$378 ﹤0.01% 1927
2013
Q4
$174K Buy
8,512
+892
+12% +$17.3K ﹤0.01% 1938
2013
Q3
$147K Hold
7,620
﹤0.01% 1984
2013
Q2
$136K Buy
+7,620
New +$138K ﹤0.01% 1950

Other funds holding HQL

PNC Financial Services Group's HQL Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in abrdn Life Sciences Investors (HQL) in Q2 2026: 4,828 shares worth $96.6K. The stake represents ﹤0.01% of the portfolio and ranks #2945 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in HQL as recently as Q4 2025.

PNC Financial Services Group first reported a position in HQL in Q2 2013 and has held it in 50 quarters since. The position peaked at $218K in Q2 2024. 45 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • PNC Financial Services Group held 4,828 shares of abrdn Life Sciences Investors worth $96.6K as of Q2 2026.
  • abrdn Life Sciences Investors was a new PNC Financial Services Group position in Q2 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2945 holding.
  • PNC Financial Services Group first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 50 quarters since.
  • PNC Financial Services Group's abrdn Life Sciences Investors position peaked at $218K in Q2 2024.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.